CELG : Summary for Celgene Corporation - Yahoo Finance

U.S. Markets closed

Celgene Corporation (CELG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
123.15+0.89 (+0.73%)
At close: 4:00PM EDT

123.15 0.00 (0.00%)
After hours: 6:30PM EDT

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close122.26
Bid122.82 x 100
Ask123.60 x 200
Day's Range122.99 - 123.90
52 Week Range94.42 - 127.64
Avg. Volume3,714,696
Market Cap95.81B
PE Ratio (TTM)49.46
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals2 hours ago

    Celgene research leader Dr. Rupert Vessey joins Juno board

    Juno Therapeutics Inc. has added Celgene Corp. President of Research and Early Development Dr. Rupert Vessey to the Seattle-based biotech's board. Vessey will serve as as Celgene's designated appointee to Juno's board, replacing Dr. Tom Daniel, who retired last summer but will remain on the board as an independent director. Juno (JUNO) inked a $1 billion collaboration with Celegene in 2015.

  • Celgene (CELG) to Post Q1 Earnings: What's in the Cards?
    Zacks4 hours ago

    Celgene (CELG) to Post Q1 Earnings: What's in the Cards?

    Celgene Corporation (CELG) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.

  • Capital Cube4 hours ago

    Celgene Corp. – Value Analysis (NASDAQ:CELG) : April 24, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Celgene Corp. a score of 78. Our analysis is based on comparing Celgene Corp. with the following peers – Amgen Inc., Gilead Sciences, Inc., Biogen Inc., OncoMed Pharmaceuticals, Inc., Eli Lilly and Company, Alexion Pharmaceuticals, Inc., Johnson & Johnson, Illumina, Inc., Novartis AG Sponsored ADR and Acceleron ... Read more (Read more...)